Wadhane Jitendra (CIK 1941706) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-25). Recent activity: Buy PYXS (109,461 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-25 | Pyxis Oncology, Inc. (PYXS) | Prin Fin & Acct Officer | Buy | 109,461 | $0 |
Source: SEC Form 4 filings · as of 2026-03-25